Publications by authors named "Michela Silacci"

Claim this Profile
A
A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases.
Michael Lyman, Vincent Lieuw, Robyn Richardson, Anjuli Timmer, Christine Stewart, Michela Silacci

J Biol Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases.
Michela Silacci, Wibke Lembke, Richard Woods, Isabella Attinger-Toller, Nadja Baenziger-Tobler

MAbs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linker length matters, fynomer-Fc fusion with an optimized linker displaying picomolar IL-17A inhibition potency.
Michela Silacci, Nadja Baenziger-Tobler, Wibke Lembke, Wenjuan Zha, Sarah Batey

J Biol Chem· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.
Eveline Trachsel, Frank Bootz, Michela Silacci, Manuela Kaspar, Hartwig Kosmehl

Arthritis Res Ther· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo.
Tobias von Lukowicz, Michela Silacci, Matthias T Wyss, Eveline Trachsel, Christine Lohmann

J Nucl Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo.
Michela Silacci, Simon S Brack, Nicolas Späth, Alfred Buck, Sven Hillinger

Protein Eng Des Sel· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.
Alexander Berndt, Katharina Anger, Petra Richter, Laura Borsi, Simon Brack, Michela Silacci

J Cancer Res Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant antibodies for the depletion of abundant proteins from human serum.
Anna Ettorre, Christoph Rösli, Michela Silacci, Simon Brack, Gregor McCombie

Proteomics· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.
Simon S Brack, Michela Silacci, Manfred Birchler, Dario Neri

Clin Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, construction, and characterization of a large synthetic human antibody phage display library.
Michela Silacci, Simon Brack, Giulia Schirru, Jessica Mårlind, Anna Ettorre

Proteomics· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity-capture reagents for protein arrays.
Giuliano Elia, Michela Silacci, Simone Scheurer, Jörg Scheuermann, Dario Neri

Trends Biotechnol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis